Luminoma Diagnostics Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Early Stage VC
- (In Progress)
- Latest Deal Amount
-
$8M
- Investors
-
7
Luminoma Diagnostics General Information
Description
Developer of a portable laser-based diagnostic device designed to screen skin lesions for cancer, operating in the healthcare industry. The company offers a device combining Raman spectroscopy with machine learning algorithms for non-invasive lesion assessment, enabling dermatologists and other healthcare professionals to evaluate malignancy risk, improve diagnostic accuracy, and reduce unnecessary biopsies.
Contact Information
Website
www.luminomadx.comCorporate Office
- Suite 1, Level 18
- 125 Queen Street
- Auckland, 1010
- New Zealand
Corporate Office
- Suite 1, Level 18
- 125 Queen Street
- Auckland, 1010
- New Zealand
Luminoma Diagnostics Timeline
Luminoma Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | 05-Nov-2026 | $8M | In Progress | Product Development | ||
| 4. Early Stage VC | 25-Nov-2025 | Completed | Product Development | |||
| 3. Early Stage VC | 28-May-2024 | Completed | Stealth | |||
| 2. Early Stage VC | 12-Dec-2023 | $243K | $243K | Completed | Stealth | |
| 1. University Spin-Out | 11-Aug-2023 | Completed | Stealth |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Luminoma Diagnostics Patents
Luminoma Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024282292-A1 | Analysis system and probe assembly | Pending | 31-May-2023 | ||
| EP-4719174-A1 | Analysis system and probe assembly | Pending | 31-May-2023 | ||
| GB-2644555-A | Analysis system and probe assembly | Pending | 31-May-2023 | ||
| US-20260354746-A1 | Analysis system and probe assembly | Pending | 31-May-2023 | ||
| WO-2024248633-A1 | Analysis system and probe assembly | Inactive | 31-May-2023 | A61B5/0075 |
Luminoma Diagnostics Signals
Luminoma Diagnostics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Flying Kiwi Angels | Angel Group | Minority | ||
| Us Angels | Corporation | Minority | ||
| Angel HQ | Angel Group | Minority | ||
| Auckland UniServices | Corporate Venture Capital | Minority | ||
| Bridgewest Ventures | Accelerator/Incubator | Minority |
Luminoma Diagnostics FAQs
-
When was Luminoma Diagnostics founded?
Luminoma Diagnostics was founded in 2023.
-
Where is Luminoma Diagnostics headquartered?
Luminoma Diagnostics is headquartered in Auckland, New Zealand.
-
What is the size of Luminoma Diagnostics?
Luminoma Diagnostics has 10 total employees.
-
What industry is Luminoma Diagnostics in?
Luminoma Diagnostics’s primary industry is Diagnostic Equipment.
-
Is Luminoma Diagnostics a private or public company?
Luminoma Diagnostics is a Private company.
-
What is the current valuation of Luminoma Diagnostics?
The current valuation of Luminoma Diagnostics is .
-
What is Luminoma Diagnostics’s current revenue?
The current revenue for Luminoma Diagnostics is .
-
How much funding has Luminoma Diagnostics raised over time?
Luminoma Diagnostics has raised $3.81M.
-
Who are Luminoma Diagnostics’s investors?
Flying Kiwi Angels, Us Angels, Angel HQ, Auckland UniServices, and Bridgewest Ventures are 5 of 7 investors who have invested in Luminoma Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process